University of Washington

Health Systems and Population Health

SCHOOL OF PUBLIC HEALTH

An evaluation of the cost-effectiveness of omalizumab for the treatment of severe allergic asthma.


  1. Home


  2. An evaluation of the cost-effectiveness of omalizumab for the treatment of severe allergic asthma.


  3. An evaluation of the cost-effectiveness of omalizumab for the treatment of severe allergic asthma.

rakerr2

Sullivan SD, Turk F. An evaluation of the cost-effectiveness of omalizumab for the treatment of severe allergic asthma. Allergy. 2008 Jun;63(6):670-84. doi: 10.1111/j.1398-9995.2008.01723.x. Review.

Upcoming Events

Full Calendar

News Categories